IOF vs. TET, SYNT, HAYD, WCH, ITX, DCTA, HDD, BIOM, ZED, and ESKN
Should you be buying Iofina stock or one of its competitors? The main competitors of Iofina include Treatt (TET), Synthomer (SYNT), Haydale Graphene Industries (HAYD), Wilmcote Holdings plc (WCH.L) (WCH), Itaconix (ITX), Directa Plus (DCTA), Hardide (HDD), Biome Technologies (BIOM), Zenova Group (ZED), and Esken (ESKN). These companies are all part of the "specialty chemicals" industry.
Iofina vs. Its Competitors
Iofina (LON:IOF) and Treatt (LON:TET) are both small-cap basic materials companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, media sentiment, profitability, valuation, dividends, analyst recommendations and risk.
Iofina presently has a consensus target price of GBX 37.50, suggesting a potential upside of 54.96%. Treatt has a consensus target price of GBX 386.67, suggesting a potential upside of 46.46%. Given Iofina's higher possible upside, analysts plainly believe Iofina is more favorable than Treatt.
0.5% of Iofina shares are owned by institutional investors. Comparatively, 42.1% of Treatt shares are owned by institutional investors. 13.4% of Iofina shares are owned by insiders. Comparatively, 4.1% of Treatt shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
In the previous week, Treatt had 16 more articles in the media than Iofina. MarketBeat recorded 17 mentions for Treatt and 1 mentions for Iofina. Treatt's average media sentiment score of 0.43 beat Iofina's score of 0.00 indicating that Treatt is being referred to more favorably in the news media.
Iofina has a beta of 0.71, meaning that its share price is 29% less volatile than the S&P 500. Comparatively, Treatt has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500.
Treatt has higher revenue and earnings than Iofina. Treatt is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.
Treatt has a net margin of 7.88% compared to Iofina's net margin of 6.98%. Treatt's return on equity of 8.09% beat Iofina's return on equity.
Summary
Treatt beats Iofina on 12 of the 15 factors compared between the two stocks.
Get Iofina News Delivered to You Automatically
Sign up to receive the latest news and ratings for IOF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding IOF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
This page (LON:IOF) was last updated on 9/12/2025 by MarketBeat.com Staff
